GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $556,000 | -8.6% | 12,900 | -10.5% | 0.01% | 0.0% |
| Q1 2017 | $608,000 | -1.1% | 14,419 | -9.8% | 0.01% | -12.5% |
| Q4 2016 | $615,000 | -96.7% | 15,981 | -96.3% | 0.01% | -96.5% |
| Q3 2016 | $18,867,000 | -48.4% | 437,436 | -48.1% | 0.23% | +0.4% |
| Q2 2016 | $36,560,000 | +129.5% | 843,552 | +114.7% | 0.23% | +7.1% |
| Q1 2016 | $15,932,000 | +7.5% | 392,893 | +7.0% | 0.21% | +5.0% |
| Q4 2015 | $14,823,000 | +9.3% | 367,360 | +4.2% | 0.20% | +11.0% |
| Q3 2015 | $13,559,000 | +2291.4% | 352,643 | +2492.0% | 0.18% | +2485.7% |
| Q2 2015 | $567,000 | -11.4% | 13,605 | -1.8% | 0.01% | -12.5% |
| Q1 2015 | $640,000 | +12.3% | 13,860 | +3.8% | 0.01% | +33.3% |
| Q4 2014 | $570,000 | -13.5% | 13,347 | -6.9% | 0.01% | -14.3% |
| Q3 2014 | $659,000 | -70.9% | 14,332 | -66.2% | 0.01% | -68.2% |
| Q2 2014 | $2,267,000 | +81.7% | 42,397 | +70.4% | 0.02% | +37.5% |
| Q3 2013 | $1,248,000 | -1.6% | 24,875 | -2.0% | 0.02% | -5.9% |
| Q2 2013 | $1,268,000 | – | 25,375 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |